TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
as of Jul 4
13,151 of 17,590 US stocks up today

A buy, hold or sell call on any US stock — traceable to the filing.

Conviction, a full thesis, a TENK Score and fair value — every figure cited to an SEC filing, not vibes.

TryAAPLMSFTNVDAGOOGLAMZNMETATSLACOST
1,195+stocks ratedEvery figurecited to a filing1,195quality-scoredSee the track record →
Browse all 50,000+ US securities →

Impersonal research — not financial advice. Past performance ≠ future results.

✶Today's call
ACN
Accenture plc
B-
Buy+77.98% to fair value

A 24.6% ROE, steadily compounding, asset-light services franchise trading at just 10.2x earnings — quality on sale.

Read the full SEC-grounded report →
Market breadth
13151 up4439 down
Advancers
13,151
75% of market
Decliners
4,439
25% of market
LeadingHealth Care+2.12%
LaggingInformation Technology-2.96%

Best buys nowour top Buy-rated stocks by TENK Score

screener →
B+GLBuy
Financials+58.86% to fair value
B+NIBuy
Utilities+54.96% to fair value
B+UTHRBuy
Health Care+45.97% to fair value
B+QLYSBuy
Information Technology+13.42% to fair value
B+CPAYBuy
Financials+17.65% to fair value
B+EVRBuy
Financials+55.82% to fair value

Top gainers

markets →
CLRO$6.48+93.43%SDOT$50.55+41.00%AVAV$190.89+37.33%ODD$17.90+25.26%FRHC$162.22+25.10%

Top losers

markets →
UPC$6.32-48.11%NVCT$19.57-31.41%SSTK$9.81-30.57%CHRN$16.49-27.87%AEHR$69.96-26.18%

Highest qualityby TENK Score

screener →
AWTMFinancialsmargin 29.6%+66.8% rev+5.32%ASONMaterialsmargin 13.3%+41.7% rev+2.26%ANLYReal Estatemargin ——+1.62%AJHGFinancialsmargin 26.3%+25.2% rev0.00%ARNRFinancialsmargin 20.9%+9.9% rev+2.98%AALLFinancialsmargin 15.2%+5.6% rev+2.97%

Fresh calls

track record →
ECHOHold

A $14.5B impairment masks a still-profitable Pay-TV core; $22.65B in forced AT&T spectrum sales is the only thing standing between ECHO and distress.

WMBHold

High-quality, FERC-regulated pipeline compounding ~18% with a huge LNG/data-center growth runway — but priced full at 34x with thin cash.

VTRSHold

Cheap, cash-generative generic-pharma value name — but revenue erodes every year and a $3.5B loss flags asset overhang; own it, don't chase.

QSell

Good AI-materials business, but 43x P/E for flat EPS and a freshly spin-off-levered balance sheet skews risk to the downside.

PEGHold

High-quality regulated utility with visible rate-base growth and nuclear PTC downside protection, but priced full at 19x — own it, don't chase it.

ORLYHold

Best-in-class auto-parts compounder, but 30x earnings on ~6% revenue growth already prices in the quality — own it, don't chase it.

Latest filings8-K

all events →
ADIMaterial agreementNew financial obligation07-02
DLTROther event07-02
EDOfficer / director change07-02
FOther event07-02
NVDAOfficer / director change07-02
NWSOther event07-02
NWSAOther event07-02

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.